❤️ Health · Axios
The dangerous risks of stopping Ozempic and GLP-1s - Axios
From Axios via USVI News: Cardiovascular and metabolic benefits may fade after treatment ends.
- That said, many GLP-1 patients have conditions such as diabetes and obesity that already carry elevated cardiovascular and metabolic risks. State of play: Millions of Americans use O…
This article is republished through the USVI News affiliate desk. Reporting, analysis, and viewpoints are those of the original publisher and do not necessarily reflect USVI News.